Literature DB >> 15259379

Cardiac natriuretic hormones, neuro-hormones, thyroid hormones and cytokines in normal subjects and patients with heart failure.

Michele Emdin1, Claudio Passino, Concetta Prontera, Annalisa Iervasi, Andrea Ripoli, Silvano Masini, Gian Carlo Zucchelli, Aldo Clerico.   

Abstract

The derangement of neuro-endocrine control of circulation influences both disease evolution and response to treatment in patients with heart failure, but little data are available about the complex relationships between the degree of neuro-hormonal activation and clinical severity. We studied the relationships between cardiac natriuretic hormones (CNHs) and several neuro-hormones and immunological markers in a prospective cohort of 105 consecutive patients with cardiomyopathy (77 men and 28 women, mean age 66.7+/-12.4 years, range 33-89 years). We assayed the circulating levels of CNHs (atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP)), plasma renin activity (PRA), aldosterone, cortisol, adrenaline, noradrenaline, thyroid hormones and thyroid stimulating hormone (TSH), tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6). The concentrations of all CNHs and neurohormones were higher in patients with heart failure compared to normal subjects, except for free triiodothyronine (FT3), which was below normal values. ANP was positively related to NYHA class, IL-6, adrenaline, noradrenaline and cortisol, while negatively with ejection fraction and FT3. BNP was positively related to age, NYHA class, IL-6, TNF-alpha, adrenaline, noradrenaline and cortisol, while negatively with ejection fraction and FT3. A stepwise multiple linear regression indicated that plasma ANP depended only on ejection fraction, adrenaline and noradrenaline values, while for plasma BNP variation NYHA class contributed too. Our data confirm a progressive activation of hormonal and immunological systems in patients with heart failure. Furthermore, CNH circulating levels in heart failure are affected not only by cardiac function and disease severity, but also by activation of neuro-hormonal and stress-related cytokine systems, as well as by the thyroid hormones, even on usual medical treatment.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15259379     DOI: 10.1515/CCLM.2004.108

Source DB:  PubMed          Journal:  Clin Chem Lab Med        ISSN: 1434-6621            Impact factor:   3.694


  13 in total

Review 1.  The role of thyroid hormone in the pathophysiology of heart failure: clinical evidence.

Authors:  E Galli; A Pingitore; G Iervasi
Journal:  Heart Fail Rev       Date:  2008-12-27       Impact factor: 4.214

2.  Depression and thyroid axis function in coronary artery disease: impact of cardiac impairment and gender.

Authors:  Robertas Bunevicius; Giedrius Varoneckas; Arthur J Prange; Alan L Hinderliter; Vilte Gintauskiene; Susan S Girdler
Journal:  Clin Cardiol       Date:  2006-04       Impact factor: 2.882

3.  A meta-analysis of proinflammatory cytokines in chronic heart failure.

Authors:  Mao Liu; Jian Chen; Dan Huang; Jianting Ke; Wei Wu
Journal:  Heart Asia       Date:  2014-09-06

4.  Cation dyshomeostasis and cardiomyocyte necrosis: the Fleckenstein hypothesis revisited.

Authors:  Brian J Borkowski; Yaser Cheema; Atta U Shahbaz; Syamal K Bhattacharya; Karl T Weber
Journal:  Eur Heart J       Date:  2011-03-12       Impact factor: 29.983

5.  Mitochondrial and energetic cardiac phenotype in hypothyroid rat. Relevance to heart failure.

Authors:  Yoni Athéa; Anne Garnier; Dominique Fortin; Lahoucine Bahi; Vladimir Veksler; Renée Ventura-Clapier
Journal:  Pflugers Arch       Date:  2007-07-19       Impact factor: 3.657

6.  Morphologies and prognostic significance of left ventricular volume/time curves with cardiac magnetic resonance in patients with non-ischaemic heart failure and left bundle branch block.

Authors:  Alberto Aimo; Alessandro Valleggi; Andrea Barison; Sara Salerni; Michele Emdin; Giovanni Donato Aquaro
Journal:  Int J Cardiovasc Imaging       Date:  2021-02-26       Impact factor: 2.357

7.  Assessment of natriuretic peptides: the heart should be evaluated as a whole.

Authors:  Emre Yalcinkaya; Murat Celik; Galip Buyukturan
Journal:  Arq Bras Cardiol       Date:  2014-03       Impact factor: 2.000

8.  The impact of aerobic exercise training with vascular occlusion in patients with chronic heart failure.

Authors:  Yasushi Tanaka; Yudai Takarada
Journal:  ESC Heart Fail       Date:  2018-03-25

9.  Prediction of the Chemoreflex Gain by Common Clinical Variables in Heart Failure.

Authors:  Gianluca Mirizzi; Alberto Giannoni; Andrea Ripoli; Giovanni Iudice; Francesca Bramanti; Michele Emdin; Claudio Passino
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

10.  Cardiac Hypertrophy and Brain Natriuretic Peptide Levels in an Ovariectomized Rat Model Fed a High-Fat Diet.

Authors:  Gleisy Kelly Goncalves; Thiago Henrique Caldeira de Oliveira; Najara de Oliveira Belo
Journal:  Med Sci Monit Basic Res       Date:  2017-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.